Stokes & Hubbell Capital Management’s Eli Lilly LLY Stock Holding History

Stokes & Hubbell Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$464K	Buy	3,575 +11	+0.3%	+$1.34K	0.1%	96
2018 Q4	$412K	Buy	3,564 +11	+0.3%	+$1.23K	0.09%	95
2018 Q3	$381K	Buy	3,553 +12	+0.3%	+$1.2K	0.08%	102
2018 Q2	$302K	Buy	3,541 +39	+1%	+$3.2K	0.07%	110
2018 Q1	$271K	Buy	3,502 +16	+0.5%	+$1.29K	0.06%	111
2017 Q4	$294K	Sell	3,486 -172	-5%	-$14.6K	0.07%	101
2017 Q3	$313K	Buy	3,658 +15	+0.4%	+$1.23K	0.08%	95
2017 Q2	$300K	Buy	+3,643	New	+$297K	0.09%	89

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Stokes & Hubbell Capital Management's LLY Position: Q1 2019 in Review

Stokes & Hubbell Capital Management increased its Eli Lilly (LLY) stake by 0.31% in Q1 2019, buying an estimated $1.34K and bringing the position to 3,575 shares worth $464K. The position accounts for 0.1% of the portfolio, ranked #96.

Stokes & Hubbell Capital Management first reported a position in LLY in Q2 2017 and has held it in 8 quarters since. 1,605 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

Stokes & Hubbell Capital Management held 3,575 shares of Eli Lilly worth $464K as of Q1 2019.
Stokes & Hubbell Capital Management bought 11 Eli Lilly shares in Q1 2019, an estimated $1.34K.
Eli Lilly made up 0.1% of Stokes & Hubbell Capital Management's portfolio in Q1 2019, its #96 holding.
Stokes & Hubbell Capital Management first reported a position in Eli Lilly in Q2 2017 and has held it in 8 quarters since.
1,605 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on Stokes & Hubbell Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.